Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by end of 2016.
Jazz Lock represents the first of a range of polyester band-based products to treat degenerative spinal conditions. The company announced FDA 510(k) clearance and CE Mark approval for the device in early 2Q16.
Sources: Implanet; ORTHOWORLD Inc.